Skip to search formSkip to main contentSkip to account menu

amediplase

Known as: K2tu-PA 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (1)

CGP 42935

Broader (3)

Recombinant ProteinsUrokinasealteplase

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Amediplase
2006
2006
Fibrinolytic efficacy of Amediplase, Tenecteplase and scu-PA in different external plasma clot lysis models
Summary In this study, the in-vitro fibrinolytic efficacy of Tenecteplase, Amediplase and scu-PA was investigated in different… 
2006
2006
ID: 141 Fibrinolytic efficacy of Amediplase, Tenecteplase and scu-PA in different external plasma clot lysis models. Sensitivity to the inhibitory action of thrombin activatable fibrinolysis…
Review
2004
Review
2004
Amediplase. Menarini.
Amediplase, a chimeric protein containing functional domains of both tissue plasminogen activator and pro-urokinase plasminogen… 
2002
2002
Amediplase: CGP 42935, K2tu-PA, MEN 9036.
Amediplase [CGP 42935, MEN 9036, K2tu-PA] is a recombinant chimeric plasminogen activator, consisting of the kringle 2 domain… 
2001
2001
Evaluation of Two Weight-Adjusted Single Bolus Doses of Amediplase to Patients with Acute Myocardial Infarction: the 3K2 Trial
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)